Clinical Trial Update: Healthcare Cost and Resource Utilization Related to Metastatic Renal Cell Carcinoma Treatment With Intravenous and Oral Agents

View source ↗

Summary

A clinical trial evaluating healthcare costs and resource utilization for metastatic renal cell carcinoma treatments using intravenous and oral agents, sponsore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Renal Cell Carcinoma | Status: WITHDRAWN